Articles with "mdm2 p53" as a keyword



Cyclo‐glycylproline attenuates hydrogen peroxide‐induced cellular damage mediated by the MDM2‐p53 pathway in human neural stem cells

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Cellular Physiology"

DOI: 10.1002/jcp.30940

Abstract: Cyclo‐glycylproline (cGP), a cyclic dipeptide containing a condensation bond between glycine and proline, is produced by the cyclization of the N‐terminal tripeptide of insulin‐like growth factor‐1. Previous studies have shown that cGP administration exerts a… read more here.

Keywords: cgp; damage; oxidative stress; brain ... See more keywords

Targeted Degradation of MDM2 as a New Approach to Improve the Efficacy of MDM2-p53 Inhibitors.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.8b01945

Abstract: MDM2 is a key oncogenic protein that serves as a negative regulator of the tumor suppressor p53. While a number of inhibitors of the MDM2-p53 interaction have progressed to clinical testing as treatments for a… read more here.

Keywords: improve efficacy; mdm2 p53; targeted degradation;

Fenpropathrin Induces GLT-1 Ubiquitination and Increases IL-6 Secretion through the Mdm2-p53 Pathway.

Sign Up to like & get
recommendations!
Published in 2023 at "ACS chemical neuroscience"

DOI: 10.1021/acschemneuro.3c00112

Abstract: Human exposure to fenpropathrin, a widely used pesticide, is linked to Parkinson's-like symptoms in the body. However, a specific pathogenic mechanism is still unclear. This study found that fenpropathrin increased the expression of murine double… read more here.

Keywords: mdm2; p53 pathway; secretion; p53 ... See more keywords

Induction of the 5S RNP–Mdm2–p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia

Sign Up to like & get
recommendations!
Published in 2017 at "Leukemia"

DOI: 10.1038/leu.2016.159

Abstract: Mutations resulting in constitutive activation of signaling pathways that regulate ribosome biogenesis are among the most common genetic events in acute myeloid leukemia (AML). However, whether ribosome biogenesis presents as a therapeutic target to treat… read more here.

Keywords: induction; mdm2 p53; rnp mdm2;

Tumor hypoxia evidences the differential regulation of Mdm2-p53 axis by PTEN in tumor derived vs. normal endothelial cells

Sign Up to like & get
recommendations!
Published in 2024 at "Scientific Reports"

DOI: 10.1038/s41598-024-82638-7

Abstract: Hypoxia, a condition of oxygen tension lower than physiological level, plays a crucial role in shaping the tumor microenvironment and modulates distinct cell populations activity. The tumor suppressor PTEN regulates angiogenesis, a process involving endothelial… read more here.

Keywords: mdm2 p53; tumor; mec; activity ... See more keywords

Melatonin protects against nonylphenol caused pancreatic β-cells damage through MDM2-P53-P21 axis.

Sign Up to like & get
recommendations!
Published in 2022 at "Toxicology research"

DOI: 10.1093/toxres/tfac016

Abstract: Nonylphenol (NP) is an endocrine disrupting chemical, which widely exists in environment and can result in multiple system dysfunction. Pancreas as one of the most important organs is sensitive to NP, while the detail toxic… read more here.

Keywords: dysfunction; p53 p21; mdm2 p53; p21 axis ... See more keywords

Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library

Sign Up to like & get
recommendations!
Published in 2017 at "Science Advances"

DOI: 10.1126/sciadv.1701383

Abstract: The unspliced form of XBP1 stabilizes MDM2 protein by inhibiting its ubiquitination and regulates the MDM2/p53 axis. Cell cycle progression is a tightly controlled fundamental process in living cells, with any defects being closely linked… read more here.

Keywords: p53 axis; p53; regulator; mdm2 p53 ... See more keywords

USP49-Mediated Histone H2B Deubiquitination Regulates HCT116 Cell Proliferation through MDM2-p53 Axis

Sign Up to like & get
recommendations!
Published in 2022 at "Molecular and Cellular Biology"

DOI: 10.1128/mcb.00434-21

Abstract: Posttranslational histone modifications play important roles in regulating chromatin structure and transcriptional regulation. Histone H2B monoubiquitination (H2Bub) is an essential regulator for transcriptional elongation and ongoing transcription. ABSTRACT Posttranslational histone modifications play important roles in… read more here.

Keywords: cell proliferation; mdm2; histone h2b; hct116 cell ... See more keywords

Qishen Granule Protects against Doxorubicin-Induced Cardiotoxicity by Coordinating MDM2-p53-Mediated Mitophagy and Mitochondrial Biogenesis

Sign Up to like & get
recommendations!
Published in 2022 at "Oxidative Medicine and Cellular Longevity"

DOI: 10.1155/2022/4344677

Abstract: Doxorubicin (DOX), the anthracycline chemotherapeutic agent, is widely used for the treatment of various cancers. However, its clinical application is compromised by dose-dependent and fatal cardiotoxicity. This study is aimed at investigating the cardioprotective effects… read more here.

Keywords: mitochondrial biogenesis; mitophagy mitochondrial; cardiotoxicity; p53 ... See more keywords

Abstract 4190: A promising blood-brain-barrier penetrant MDM2-p53 antagonist, BI-MDM2, increases survival in orthotopic, glioblastoma patient-derived xenograft models

Sign Up to like & get
recommendations!
Published in 2020 at "Cancer Research"

DOI: 10.1158/1538-7445.am2020-4190

Abstract: Robust function of the p53 tumor suppressor pathway is critical when treating with DNA-damage inducing agents such as radiation therapy (RT), which is a key component of standard care for GBM. MDM2 is an important… read more here.

Keywords: antagonist mdm2; mdm2; penetrant mdm2; p53 antagonist ... See more keywords

Abstract LB003: BI 907828: A highly potent MDM2-p53 antagonist suitable for intermittent dose schedules

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-lb003

Abstract: The E3 ligase MDM2 controls the tumor suppressor function of p53, which is encoded by the TP53gene. Compounds designed to bind to MDM2 preventing its interaction with p53 restore the ability of p53 to combat… read more here.

Keywords: highly potent; mdm2; 907828 highly; potent mdm2 ... See more keywords